Pediatric multicenter evaluation of the Verigene Gram-negative blood culture test for rapid detection of inpatient bacteremia involving Gram-negative organisms, extended-spectrum beta-lactamases, and carbapenemases

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2416-2421

  Sullivan, K V ^a,b   Deburger, B ^c   Roundtree, S S ^a   Ventrola, C A ^c   Blecker Shelly, D L ^a   Mortensen, J E ^c,d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE IMP; BETA LACTAMASE KPC; BETA LACTAMASE NDM; BETA LACTAMASE OXA; BETA LACTAMASE VIM; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM EXAMINATION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CITROBACTER; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; GOLD STANDARD; GRAM NEGATIVE BLOOD CULTURE TEST; HOSPITAL PATIENT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROARRAY ANALYSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS; SERRATIA MARCESCENS; SHIGELLA; CLASSIFICATION; CLINICAL TRIAL; COINFECTION; COMPARATIVE STUDY; CROSS INFECTION; DIAGNOSTIC ERROR; ENZYMOLOGY; EVALUATION STUDY; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; SECRETION (PROCESS); SENSITIVITY AND SPECIFICITY;

BACTEREMIA; BETA-LACTAMASES; COINFECTION; CROSS INFECTION; DIAGNOSTIC ERRORS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INPATIENTS; SENSITIVITY AND SPECIFICITY;

EID: 84903766746     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00737-14     Document Type: Article

References (29)

1. Al-Hasan MN, Huskins WC, Lahr BD, Eckel-Passow JE, Baddour LM. 2011. Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study. Epidemiol. Infect. 139:791-796. http://dx.doi.org/10. 1017/S0950268810001640.
2. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. 2003. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr. Infect. Dis. J. 22:686-691. http://dx.doi.org/10.1097/01.inf.0000078159.53132. 40. (Pubitemid 36999643)
3. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. 2004. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:3720-3728. http://dx.doi.org/10.1128/AAC.48.10.3720-3728.2004. (Pubitemid 39304595)
4. Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, Kim JH, Kim EC. 2002. Bloodstream infections by extended-spectrum-β-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob. Agents Chemother. 46:1481-1491. http://dx.doi.org/10.1128/AAC.46.5.1481-1491.2002. (Pubitemid 34415332)
5. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S, Carmeli Y. 2010. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 54:5099-5104. http://dx.doi.org/10.1128/AAC.00565-10.
6. Schwaber MJ, Carmeli Y. 2007. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60:913-920. http://dx.doi.org/10.1093/jac/dkm318. (Pubitemid 47617735)
7. Sullivan KV, Turner NN, Roundtree SS, Young S, Brock-Haag CA, Lacey D, Abuzaid S, Blecker-Shelly DL, Doern CD. 2013. Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation. J. Clin. Microbiol. 51:3579-3584. http://dx.doi.org/10.1128/JCM.01224-13.
8. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. 2012. Evaluation of a DNA microarray for the rapid detection of extendedspectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J. Antimicrob. Chemother. 67:1865-1869. http://dx.doi.org/10.1093/jac/dks156.
9. Centers for Disease Control and Prevention. 2011. Multiplex real-time PCR detection of Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM-1) genes. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/HAI/settings/lab/kpc-ndm1-lab- protocol.html.
10. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. 2009. Prevalence of CTX-M-lactamases in Philadelphia, Pennsylvania. J. Clin. Microbiol. 47:2970-2974. http://dx.doi.org/10.1128/JCM.00319-09.
11. Clerc O, Prod'hom G, Vogne C, Bizzini A, Calandra T, Greub G. 2013. Impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin. Infect. Dis. 56:1101-1107. http://dx.doi.org/10.1093/cid/cis1204.
12. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption ionization-time of flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin. Infect. Dis. 57:1237-1245. http://dx.doi.org/10.1093/cid/cit498.
13. Jacoby JA. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182. http://dx.doi.org/10.1128/CMR.00036-08.
14. Tamma PD, Girdwood SC, Gopaul R, Tekle T, Roberts AA, Harris AD, Cosgrove SE, Carroll KC. 2013. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae. Clin. Infect. Dis. 57:781-788. http://dx.doi.org/10.1093/cid/cit395.
15. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL. 2004. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis. 39:31-37. http://dx.doi.org/10.1086/420816. (Pubitemid 38879546)
16. Rodríguez-Baño J, Navarro MD, Retamar P, Picón E, Pascual Á Extended-Spectrum Beta-Lactamases-Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. 2012. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin. Infect. Dis. 54:167-174. http://dx.doi.org/10.1093/cid/cir790.
17. Centers for Disease Control and Prevention. 2006. Management of multidrug-resistant organisms in healthcare settings, 2006. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hicpac/mdro/mdro-4.html.
18. Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance. 2013. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase-and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5-year period: CANWARD 2007-11. J. Antimicrob. Chemother. 68(Suppl1):57-65. http://dx.doi.org/10.1093/jac/dkt027.
19. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53:60-67. http://dx.doi.org/10.1093/cid/cir202.
20. Lee GC, Burgess DS. 2012. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann. Clin. Microbiol. Antimicrob. 3:1-9. http://dx.doi.org/10.1186/ 1476-0711-11-32.
21. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. 2012. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin. Infect. Dis. 55:943-950. http://dx.doi.org/10.1093/ cid/cis588.
22. Munoz-Price LS, De La Cuesta C, Adams S, Wyckoff M, Cleary T, McCurdy SP, Huband MD, Lemmon MM, Lescoe M, Dibhajj FB, Hayden MK, Lolans K, Quinn JP. 2010. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect. Control Hosp. Epidemiol. 31:1074-1077. http://dx.doi.org/10.1086/656243.
23. Centers for Disease Control and Prevention. 2014. Notes from the field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography-Illinois, 2013. MMWR Morb. Mort. Wkly. Rep. 62:1051.
24. Centers for Disease Control and Prevention. 2012. 2012 CRE toolkit-guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hai/ organisms/cre/cre-toolkit/index.html.
25. Queenan AM, Bush K. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458. http://dx.doi.org/10.1128/CMR.00001-07.
26. Samuel LP, Tibbetts RJ, Agotesku A, Fey M, Hensley R, Meier FA. 2013. Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J. Clin. Microbiol. 51:1188-1192. http://dx.doi.org/10.1128/JCM.02982-12.
27. Wojewoda CM, Sercia L, Navas M, Tuohy M, Wilson D, Hall GS, Procop GW, Richter SS. 2013. Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants. J. Clin. Microbiol. 51:2072-2076. http://dx.doi.org/10.1128/JCM.00831-13.
28. McKenzie FE. 2006. Case mortality in polymicrobial bloodstream infections. J. Clin. Epidemiol. 59:760-761. http://dx.doi.org/10.1016/j. jclinepi.2005.12.009. (Pubitemid 43825725)
29. Bonadio WA. 1988. Polymicrobial bacteremia in children. An 11-year experience. Am. J. Dis. Child. 142:1158-1160. http://dx.doi.org/10.1001/ archpedi.1988.02150110036014. (Pubitemid 18260784)